Back to Search

KROS

Keros Therapeutics, Inc. Common Stock
Data: 2026-08-21
$11.03
Price
0.73%
Change
$22.55
52W High
$9.69
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Quick Stats
Aug 21, 2026

48.8

AI Score

HOLD

0.76

Volume Ratio

TBA

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

KROS Stock Summary

Last updated Aug 21, 2026

KROS is currently trading at $11.03, positioned below its 200-day moving average of $13.92, suggesting bearish momentum. The stock has a 52-week range of $9.69 to $22.55.

Technical Analysis: The 50-day moving average stands at $10.67, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.008, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.223, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KROS at 48.8/100 with a HOLD recommendation.

KROS (Keros Therapeutics, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 55.008
CMF (20) 0.223
ROC (10) -1.076
ADX (14) 22.915
Indicator Value
MACD (12,26,9) 0.078
AROONOSC (14) 50.0
WILLAMS %R (14) -22.989
MFI (14) 58.166
KROS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KROS Price vs Max Options Open Interest
KROS Max Change In Options Open Interest

KROS Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KROS Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KROS Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KROS Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Keros Therapeutics, Inc. Common Stock is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).

KROS Moving Averages Analysis

Keros Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

KROS (Keros Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 10.75
20 10.51
30 10.52
50 10.67
100 10.98
200 13.92

KROS Fundamental Analysis

P/E (Forward) 48.7805
P/E (Trailing) --
Market Cap ($) 217.1 million
Earnings/Share ($) -3.18
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -5.1417
EPS Estimate Next Year ($) -6.6133
WallStreet Target Price ($) 19.83
Most Recent Quarter